Testing version — LOERadar is in active testing. Features and data may change.
EVEROLIMUS (EVEROLIMUS) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
EVEROLIMUS
ANDANot in Orange Book
EVEROLIMUS | A220597 | NOVITIUM PHARMA
Products (3)
Sort:
#001 — 2MG
▴
TABLET, FOR SUSPENSION;ORAL | Approved: Sep. 21, 2026
No patent or exclusivity listings for this strength.
#002 — 3MG
▾
TABLET, FOR SUSPENSION;ORAL | Approved: Sep. 21, 2026
#003 — 5MG
▾
TABLET, FOR SUSPENSION;ORAL | Approved: Sep. 21, 2026